糖尿病患者种族差异与全因死亡率及未来并发症的系统综述与荟萃分析
该系统综述与荟萃分析纳入23项前瞻性队列研究、共2,416,516例糖尿病患者,以白人为参照,评估不同种族/族裔未来糖尿病并发症和全因死亡风险的差异。结果显示毛利人族裔全因死亡风险更高(HR 1.88, 95%CI 1.61–2.21),西班牙裔美国人CVD风险更低(HR 0.66, 95%CI 0.53–0.81),黑人终末期肾病风险更高(HR 1.54, 95%CI 1.05–2.24)。
要点
- 毛利人族裔糖尿病患者全因死亡风险显著高于白人(HR 1.88, 95%CI 1.61–2.21)。
- 西班牙裔美国人糖尿病患者CVD风险显著低于白人(HR 0.66, 95%CI 0.53–0.81)。
- 黑人糖尿病患者终末期肾病风险显著高于白人(HR 1.54, 95%CI 1.05–2.24)。
核心结论
- 糖尿病患者的未来并发症和全因死亡风险存在种族/族裔差异。
- 结果支持在更好的预测因子出现前,国际糖尿病临床指南推荐使用此类种族/族裔分类。
- 需要努力识别高风险群体并在不同族裔人群中更好地控制心血管危险因素。
研究设计与样本
- 系统检索PubMed和EMBASE从建库至2021年5月的前瞻性队列研究。
- 纳入报告种族/族裔组糖尿病并发症和全因死亡HR及95%CI、以白人为参照组的研究。
- 共纳入23项研究,涵盖2,416,516例糖尿病患者(白人59.3%、黑人11.2%、亚洲人1.3%、西班牙裔美国人2.4%、美洲原住民0.2%、东亚人1.9%、南亚人0.8%、太平洋岛民2.3%、毛利人2.4%、其他18.2%)。
- 采用随机效应逆方差模型合并估计值,并使用Hartung-Knapp-Sidik-Johnson方差估计器。
- PROSPERO注册号CRD42021239274。
主要发现
- 与白人糖尿病患者相比,毛利人族裔全因死亡风险更高(HR 1.88 [95% CI 1.61, 2.21];I2 = 7.1%)。
- 西班牙裔美国人CVD风险显著更低(HR 0.66 [95% CI 0.53, 0.81];I2 = 0%)。
- 黑人终末期肾病风险更高(HR 1.54 [95% CI 1.05, 2.24];I2 = 95.4%)。
- 其他种族/族裔组相对于白人未发现糖尿病并发症风险显著升高。
临床怎么用
- 临床中应关注毛利人族裔糖尿病患者的全因死亡高风险。
- 对黑人糖尿病患者应加强终末期肾病的筛查与管理。
- 西班牙裔美国人糖尿病患者CVD风险较低,但仍需个体化评估。
- 在更好的预测因子出现前,可参考种族/族裔分类识别高风险群体。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: The aim of this work was to quantify racial/ethnic differences in risk for future diabetic complications and all-cause mortality by performing a meta-analysis of prospective studies. METHODS: A systematic search in PubMed and EMBASE was performed from inception to May 2021. Prospective cohort studies that reported HRs and associated 95% CIs of diabetes complications and all-cause mortality among racial/ethnic groups, with White people as the reference group, were included. Study characteristics and HR estimates were extracted from each study. Estimates were pooled using random-effects inverse-variance model with the Hartung-Knapp-Sidik-Jonkman variance estimator. RESULTS: A total of 23 studies were included, comprising 2,416,516 individuals diagnosed with diabetes (White 59.3%, Black 11.2%, Asian 1.3%, Hispanic-American 2.4%, Native American 0.2%, East Asian 1.9%, South Asian 0.8%, Pacific Islander 2.3%, Māori 2.4% and others 18.2%). Compared with White individuals with diabetes, individuals of Māori ethnicity were at higher risk for all-cause mortality (HR 1.88 [95% CI 1.61, 2.21]; I2 = 7.1%), Hispanic-American individuals had a significantly lower risk for CVD (HR 0.66 [95% CI 0.53, 0.81]; I2 = 0%) and Black individuals had higher risk for end-stage renal disease (HR 1.54 [95% CI 1.05, 2.24]; I2 = 95.4%). No significant higher risk for diabetes complications was found in other racial/ethnic groups relative to White people. CONCLUSIONS/INTERPRETATION: Racial/ethnic differences exist in the risk for future diabetic complications and all-cause mortality. Our results support the use of such categories for international diabetes clinical guideline recommendations until better predictors become available. Efforts to identify high-risk groups and to better control cardiovascular risk factors across ethnically diverse populations are therefore needed. REGISTRATION: PROSPERO registration ID CRD42021239274.
引用
- Ezzatvar Y, Ramírez-Vélez R, Izquierdo M, et al. Racial differences in all-cause mortality and future complications among people with diabetes: a systematic review and meta-analysis of data from more than 2.4 million individuals. Diabetologia. 2021. PMID: 34455457. doi:10.1007/s00125-021-05554-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。